Advertisement
Advertisement
SUPN
Supernus Pharmaceuticals, Inc.
32.50
USD-0.32
-0.97%
Apr 03, 15:59 UTC -4
Closed
Pre-Market
32.33
-0.16
-0.49%
Supernus Pharmaceuticals, Inc. Profile
About
Info & Links
CEO
JACK A. KHATTAR
Headquarters
ROCKVILLE, MD 20850, UNITED STATES
Industry
Sector
Website
Auditor
KPMGLLP
Share holders
15
Employees
674
Supernus Pharmaceuticals, Inc. Statistics
Valuation Measures
Market Capitalization2
1.80B
Enterprise Value
1.74B
Enterprise Value/EBITDA(ttm)
10.59
Price to Earnings Ratio(ttm)
26.01
Price to Sales(ttm)
2.93
Price to Book(mrq)
1.90
Price to Cash(ytd)
21.83
Profitability
Gross Margin(ttm)
88.25%
Operating Margin(ttm)
11.40%
Profit Margin(ttm)
10.66%
Return on Equity(ttm)
7.79%
Return on Invested Capital(ttm)
7.40%
Return on Assets(ttm)
5.67%
Income Statement
Revenue(ttm)
661.82M
Revenue Per Share(ttm)
11.86
Gross Profit(ttm)
583.91M
EBITDA(ttm)3
163.90M
Net Income Available to Common(ttm)
73.86M
Diluted EPS(ttm)
1.07
Share Statistics
Beta (5Y Monthly)
0.90
52-Week Change
-3.99%
S&P 500 52-Week Change
4.84%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
55.81M
Dividend Yield
0.00%
Float4
50.08M
% Held by Insiders
9.30%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
453.61M
Total Cash Per Share(mrq)
8.13
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
2.35%
Quick Ratio(mrq)
1.98%
Book Value Per Share(mrq)
18.58
Cash Flow
Operating Cash Flow Per Share(ytd)
3.07
Free Cash Flow(ytd)
171.23M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement